Oncology
Day One's big bet on tovorafenib just keeps paying off
Now set to be acquired by Servier for $2.5 billion, Day One Bio proves how far a mission-driven biotech with a strong team and good timing can go.
Sales & Marketing
Pharma and wellness brands play the same game, but with diff...
It's more important than ever that pharma marketers tell their stories clearly and creatively, with a focus on educating customers.
Digital
What US healthcare companies and medical researchers need to...
How Italy’s pioneering AI Law and the EU AI Act impacts US healthcare companies and medical researchers operating in Italy.
Market Access
JPM 2026: What it revealed about biotech’s new reality
JPM 2026 signalled genuine recovery – but not the kind the industry has historically celebrated.
Sales & Marketing
Pharma’s search loophole is a preview of what comes next
PPC ads often contain so little text that they avoid direct claims. Many consist only of a brand name, a link, and limited copy.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
